Nuvalent, Inc. (NUVL)
100.35
-3.91
(-3.75%)
USD |
NASDAQ |
May 07, 13:15
Nuvalent Free Cash Flow : -275.21M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Glaukos Corp. | -35.09M |
| Edgewise Therapeutics, Inc. | -144.07M |
| Cogent Biosciences, Inc. | -286.27M |
| Neurocrine Biosciences, Inc. | 831.30M |
| Arcellx, Inc. | -212.58M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -73.33M |
| Cash from Investing (Quarterly) | -280.94M |
| Cash from Financing (Quarterly) | 500.26M |
| Free Cash Flow Per Share (Quarterly) | -0.9791 |
| Free Cash Flow to Equity (Quarterly) | -73.33M |
| Free Cash Flow to Firm (Quarterly) | -73.33M |
| Free Cash Flow Yield | -3.78% |